A ColEl plasmid from the Clarke and Carbon collection [Clarke, L. & Carbon, J. (1976) CeU 9, 91-99] that contains a 14.4-kilobase Escherichia coli DNA insert complements the rnc-105 mutation, which destroys the activity of the RNA-processing enzyme RNase III. This insert and smaller restriction endonuclease fragments derived from it were cloned into the plasmid pBR329. A number of these recombinant plasmids complemented the rnc-lOS mutation in a recA genetic background. The smallest cloned fragment that compensated for the rnc-105 mutation was 1.3 kilobase in size. This fragment led to the synthesis of two polypeptides. One of these polypeptides was 25,300 daltons and corresponded in size to the subunit of RNase HI. Fragments cloned in opposite orientations led to synthesis of RNase III, indicating that the cloned fragments contained an endogenous promoter. Extracts of an rnc' E. coli strain containing an rnc' plasmid had at least 10 times more RNase III activity than did an analogous strain containing the pBR329 plasmid.Within the past decade the importance of RNA processing has emerged in a wide variety of biological systems (1-3). The cloning of genes for precursor RNAs and RNA-processing enzymes could greatly assist the study of RNA processing. Although the genes for many RNA precursors have been cloned, thus far cloning has contributed only marginally to the study of the proteins that mediate many of the RNAprocessing reactions that occur in the cell (4-6). Since the endonuclease RNase III introduces specific cleavages in a number of RNA (rRNA, tRNA, and mRNA) precursors in Escherichia coli and bacteriophages that parasitize it (1-3), we set out to clone the gene for this enzyme. The work described here depended on the existence of the rnc-105 mutation (7) and was aided by the previous purification of RNase III (8,9) and the demonstration that this enzyme is a dimer of two homologous polypeptides, 25,000 daltons each (9).
MATERIALS AND METHODSBacterial Strains. All strains were E. coli K-12. JC10240 was srlC30::TnlO, recA56 obtained from Alvin J. Clark (10). X1411 (11) was a minicell-producing strain provided by Roy Curtiss III. N2076 was wild type for RNase III and has been described (12). N2100 was an rnc-105, arg41, purI66, str-9 strain prepared similarly to the previously described N2077 (12) with selection for NAD independence (Nad+). N3589 was an rnc-105, rne-3071 double mutant constructed similarly to N3520 (13). N3441 was constructed by a prolonged mating between an rne-3071 mutant, N3431 (14), and N7060 (12), with selection for streptomycin resistance (Strr) and tyrosine independence (Tyr'). N4021 was an recA56, rnc-105 strain constructed as follows. A Pl-mediated transduction (15) was carried out with JC10240 as donor and N2100 as recipient with selection for tetracycline resistance (Tetr). A resulting Rec-recombinant, N4019, was then used as a recipient in a P1-mediated transduction with D10 (16) as a donor and selection for sorbitol independence (Srl+). A resulting recombinant which wa...